Pentazocine and naloxone .5 mg/1 (Pentazocine hydrochloride and naloxone hydrochloride TABLET) .5 mg/1

Pentazocine and naloxone .5 mg/1 tablets combine two active ingredients for pain management. This medication is often used to alleviate moderate to severe pain while reducing the risk of misuse.

Strength

.5 mg/1

Pack Size

100 TABLET in 1 BOTTLE, PLASTIC (0591-0395-01)

Manufacturer / TM Owner

Actavis Pharma, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Pentazocine and naloxone .5 mg/1 tablets are primarily used for the management of moderate to severe pain. The combination of pentazocine, an opioid analgesic, and naloxone, an opioid antagonist, works to provide pain relief while minimizing the potential for abuse. This medication is often prescribed for conditions that require ongoing pain management, such as chronic pain or post-surgical recovery.

Side Effects

Common effects of pentazocine and naloxone .5 mg/1 tablets may include drowsiness, dizziness, nausea, and constipation. Some users may also experience headaches or mild stomach discomfort. These effects can vary from person to person and may subside as the body adjusts to the medication.

Precautions & Warnings

It is important to handle pentazocine and naloxone .5 mg/1 tablets with care. Store them in a cool, dry place away from children and pets. Always follow the prescribed dosage and administration instructions provided by your healthcare professional. Do not share this medication with others, even if they have similar symptoms.

Avoid Interactions

Pentazocine and naloxone .5 mg/1 tablets may interact with other medications, including alcohol, sedatives, and certain antidepressants. It is advisable to inform your healthcare provider about all medications you are currently taking to avoid potential interactions. Always consult with a healthcare professional before starting or stopping any medication.

Frequently Asked Questions

Pentazocine and naloxone .5 mg/1 tablets are used for managing moderate to severe pain while reducing the risk of misuse.

Always follow the dosage and administration instructions provided by your healthcare professional.

Common side effects may include drowsiness, dizziness, nausea, and constipation.

It is advisable to avoid alcohol while taking pentazocine and naloxone to prevent potential interactions.

Store pentazocine and naloxone .5 mg/1 tablets in a cool, dry place away from children and pets.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.